OREXO AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.15 USD | +7.50% |
|
+7.50% | +42.38% |
| 08/05 | Transcript : Orexo AB, Q1 2024 Earnings Call, May 08, 2024 | |
| 08/05 | Orexo AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Specialty & Advanced Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 70.02B | ||||||
| 9.05B | ||||||
| 4.43B | ||||||
| 4.16B | ||||||
| 3.83B | - | - |
- Stock Market
- Equities
- ORX Stock
- ORXOY Stock
- Charts Orexo AB
- Sector Chart
